PodParley PodParley
PodParley
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma episode artwork

EPISODE · Oct 19, 2023 · 1H 1M

What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

from Hematologic Oncology Update

Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, discuss the management of relapsed/refractory mantle cell lymphoma.

Episode metadata supplied by the publisher feed · Published Oct 19, 2023

Embed this episode

NOW PLAYING

What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

0:00 1:01:33

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Hematologic Oncology Update?

This episode is 1 hour and 1 minute long.

When was this Hematologic Oncology Update episode published?

This episode was published on October 19, 2023.

Can I download this Hematologic Oncology Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!